As the number of monkeypox cases around the world has ballooned since early May, so too has the list of diagnostic developers rapidly churning out tests for the virus.
Latest to join the likes of Labcorp, Roche, BD, Cepheid and others in that mission is Qiagen, which announced this week the launch of a monkeypox assay of its own. The test is designed to be analyzed by the company’s QIAstat-Dx PCR testing system.
Image: The QIAstat-Dx Viral Vesicular Panel is indicated for research use only, making Qiagen’s test available to the approximately 3,000 laboratories around the world that already have QIAstat-Dx PCR analyzers installed. (Qiagen)